Found: 11
Select item for more details and to access through your institution.
Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR-mutated non-small-cell lung cancer.
- Published in:
- Current Oncology, 2020, v. 27, n. 6, p. 321, doi. 10.3747/co.27.7297
- By:
- Publication type:
- Article
Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.
- Published in:
- Current Oncology, 2019, v. 26, n. 4, p. E551, doi. 10.3747/co.26.5137
- By:
- Publication type:
- Article
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
- Published in:
- Current Oncology, 2018, v. 25, n. 5, p. 317, doi. 10.3747/co.25.4379
- By:
- Publication type:
- Article
Harmonization of PD-L1 testing in oncology: a Canadian pathology perspective.
- Published in:
- Current Oncology, 2018, v. 25, n. 3, p. e209, doi. 10.3747/co.25.4031
- By:
- Publication type:
- Article
Standardizing biomarker testing for Canadian patients with advanced lung cancer.
- Published in:
- Current Oncology, 2018, v. 25, n. 1, p. 73, doi. 10.3747/co.25.3867
- By:
- Publication type:
- Article
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
- Published in:
- Current Oncology, 2016, v. 23, n. 3, p. 196, doi. 10.3747/co.23.3120
- By:
- Publication type:
- Article
Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified.
- Published in:
- Current Oncology, 2015, v. 22, n. 3, p. e164, doi. 10.3747/co.22.2339
- By:
- Publication type:
- Article
Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified.
- Published in:
- Current Oncology, 2015, v. 22, n. 3, p. e164, doi. 10.3747/co.22.2339
- By:
- Publication type:
- Article
Relationship of thyroid transcription factor 1 to EGFR status in non-small-cell lung cancer.
- Published in:
- Current Oncology, 2014, v. 21, n. 6, p. 305, doi. 10.3747/co.21.2148
- By:
- Publication type:
- Article
Impact of the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology clinical practice guidelines for EGFR and ALK testing in lung cancer in Canada.
- Published in:
- Current Oncology, 2013, v. 20, n. 4, p. 220, doi. 10.3747/co.20.1568
- By:
- Publication type:
- Article
EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer.
- Published in:
- Current Oncology, 2012, v. 19, n. 2, p. e67, doi. 10.3747/co.19.862
- By:
- Publication type:
- Article